Ondansetron oral dispersible film (Taho Pharma)

N/A

Report date: 2023/09/07 09:40:09

Base Information

Drug NameOndansetron oral dispersible film (Taho Pharma)
Drug Alias NameTAH-4411CINV-TAH4411
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTAHO Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTAHO Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A